The news story you are looking for has expired. A more recent related article is displayed below.

Ads by Google

Endocyte raises $26 million in Series C funding

Oct 16, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --

Company: Medical Ventures Corp (MVTRF)

Endocyte, Inc., a cancer drug discovery and development company, has secured $26 million in Series C funding from Clarian Health Ventures, Inc., Sanderling Ventures, Burrill & Company, American Bailey Ventures, Blue Chip Venture Company and Triathlon Medical Ventures. 

Deal Type    Venture Finance
Sub-Category None
Deal Status  Completed: 2009-10-16

Deal Participants 

Target (Company) Endocyte, Inc.

Copyright (C) 2009 Datamonitor Financial Deals Tracker. All rights reserved

News Provided by COMTEX

Company: Medical Ventures Corp (MVTRF)


Related terms: blue chip, cancer, health

Related Articles

Blue Chip Dividend Boost: 1 Minute Trade (TheStreet.com TV)
Nov 19, 2009
NEW YORK (TheStreet) -- David Peltier discusses what signals a recent dividend increase at an industry leader sends.

Tachographs Directory: Page 1
Nov 24, 2009
...at TruTac, have been providing products and services for over 10 years to the road haulage industry. Working with over 250 blue chip clients within the retailing, ind... More about TruTac The Viscount Centre University of Warwick Science Park...

BCT extends Resolution HMI SBC options: News from Blue Chip Technology
Nov 20, 2009
...Design PCs and Embedded Systems Blue Chip Technology First visit to Engineeringtalk...extends Resolution HMI SBC options A Blue Chip Technology product story More from...Engineeringtalk editorial team Nov 20, 2009 Blue Chip Technology (BCT) has followed up...

Oprah Will Narrate Discovery Channel's 'Life' Series
Nov 2, 2009
...see animals and plants up close and personal - each story more amazing. Ms. Winfrey will be the perfect complement to this blue-chip natural history television event." Winfrey is teaming with Discovery Communications on OWN: The Oprah Winfrey Network...